Precigen Inc [NASDAQ: PGEN] price surged by 10.19 percent to reach at $0.16.
A sum of 4871053 shares traded at recent session while its average daily volume was at 2.15M shares. Precigen Inc shares reached a high of $1.85 and dropped to a low of $1.6188 until finishing in the latest session at $1.73.
The one-year PGEN stock forecast points to a potential upside of 71.17. The average equity rating for PGEN stock is currently 2.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Precigen Inc [PGEN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PGEN shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PGEN stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for Precigen Inc shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on March 22, 2024. While these analysts kept the previous recommendation, JP Morgan raised their target price to Neutral. The new note on the price target was released on May 23, 2023, representing the official price target for Precigen Inc stock. Previously, the target price had yet another raise to $7, while Cantor Fitzgerald analysts kept a Overweight rating on PGEN stock.
PGEN Stock Performance Analysis:
Precigen Inc [PGEN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.22. With this latest performance, PGEN shares gained by 21.83% in over the last four-week period, additionally plugging by 36.22% over the last 6 months – not to mention a rise of 54.46% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PGEN stock in for the last two-week period is set at 54.58, with the RSI for the last a single of trading hit 0.1569, and the three-weeks RSI is set at 0.1407 for Precigen Inc [PGEN]. The present Moving Average for the last 50 days of trading for this stock 1.5446, while it was recorded at 1.6100 for the last single week of trading, and 1.3336 for the last 200 days.
Insight into Precigen Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Precigen Inc [PGEN] shares currently have an operating margin of -2211.16% and a Gross Margin at -53.65%. Precigen Inc’s Net Margin is presently recorded at -3728.87%.
Precigen Inc (PGEN) Capital Structure & Debt Analysis
According to recent financial data for Precigen Inc. ( PGEN), the Return on Equity (ROE) stands at -278.55%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -118.84%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Precigen Inc’s Return on Invested Capital (ROIC) is -785.33%, showcasing its effectiveness in deploying capital for earnings.
Precigen Inc (PGEN) Efficiency & Liquidity Metrics
Based on Precigen Inc’s (PGEN) latest financial statements, the Debt-to-Equity Ratio is 0.35%, indicating its reliance on debt financing relative to shareholder equity.
Precigen Inc (PGEN) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Precigen Inc. (PGEN) effectively leverages its workforce, generating an average of -$1095454.55 per employee. The company’s liquidity position is robust, with a Current Ratio of 3.53% and a Quick Ratio of 3.53%, indicating strong ability to cover short-term liabilities.
Precigen Inc [PGEN] Institutonal Ownership Details
There are presently around $67.09%, or 75.01% of PGEN stock, in the hands of institutional investors. The top three institutional holders of PGEN stocks are: PATIENT CAPITAL MANAGEMENT, LLC with ownership of 18.17 million shares, which is approximately 7.2017%. BLACKROCK INC., holding 10.25 million shares of the stock with an approximate value of $$16.19 million in PGEN stocks shares; and BLACKROCK INC., currently with $$10.68 million in PGEN stock with ownership which is approximately 2.6784%.
